HMPV Outbreak: Not a new virus, Here’s what you need to know about the 23-year-old threat

The recent outbreak of Human Metapneumovirus (HMPV) in China has raised global concerns, with India closely monitoring developments. Here’s a comprehensive guide to understanding HMPV, its similarities to COVID-19, symptoms, and the actions being taken to manage the situation.

What is Human Metapneumovirus (HMPV)?

Advertisement

Human Metapneumovirus (HMPV) is a common respiratory virus causing both upper and lower respiratory infections, such as colds and pneumonia. It primarily affects children under five, older adults, and individuals with weakened immune systems. HMPV is most active during the winter and early spring seasons, much like the flu and Respiratory Syncytial Virus (RSV).

Is HMPV New?

No, HMPV is not a new virus. It was first identified in 2001, but evidence suggests it has been circulating globally since at least 1958. The virus belongs to the Pneumoviridae family, alongside RSV.

How is HMPV Similar to COVID-19?

  1. Transmission: Both viruses spread through respiratory droplets, close contact, and touching contaminated surfaces.
  2. Symptoms: Common symptoms include cough, fever, nasal congestion, and shortness of breath.
  3. Seasonality: HMPV and COVID-19 demonstrate seasonal peaks, with HMPV typically surging in late winter and early spring.

Symptoms of HMPV

  • Mild Symptoms: Cough, runny or stuffy nose, sore throat, and fever.
  • Severe Symptoms: Wheezing, difficulty breathing, hoarseness, pneumonia, and exacerbation of asthma.

Is There a Vaccine or Treatment for HMPV?

Currently, no vaccine or antiviral treatment exists for HMPV. Preventive measures include:

  • Frequent handwashing for at least 20 seconds.
  • Avoiding close contact with sick individuals.
  • Using tissues or elbows to cover coughs and sneezes.
  • Not sharing eating utensils or cups.

India’s Preparedness

The Ministry of Health is closely monitoring the situation through international agencies, including the World Health Organization (WHO). India’s Integrated Disease Surveillance Programme (IDSP) and Indian Council of Medical Research (ICMR) are actively tracking respiratory virus trends.

China’s Response

China has acknowledged the seasonal surge in respiratory infections but maintains that the situation is less severe than in previous years. According to China’s foreign ministry, “It is safe to travel in China.”

Should India Be Concerned?

While no unusual surge in respiratory infections has been reported in India, experts advise vigilance. People are encouraged to take precautions, especially during the winter months, to avoid unnecessary risks.

By staying informed and practicing preventive measures, both individuals and healthcare systems can effectively manage the situation.